ATYR
aTyr Pharma·NASDAQ
--
--(--)
--
--(--)
3.33 / 10
Netural
Technical assessment reveals a score of 3.33/10, indicating a neutral and challenging structure. Constructive RSI Overbought signals are offset by adverse Long Upper Shadow and Long Lower Shadow patterns, leading to a cautious forecast.
Analysis Checks(1/3)
Long Upper Shadow
Score1.8/10
Win Rate47.30%
Hist. Signals74
Avg Return-1.58%
Score1.8/10
Win Rate47.30%
Hist. Signals74
Avg Return-1.58%
RSI Overbought
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return5.31%
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return5.31%
Long Lower Shadow
Score1.35/10
Win Rate45.65%
Hist. Signals46
Avg Return-2.39%
Score1.35/10
Win Rate45.65%
Hist. Signals46
Avg Return-2.39%
Long Upper Shadow
Score1.8/10
Win Rate47.30%
Hist. Signals74
Avg Return-1.58%
Score1.8/10
Win Rate47.30%
Hist. Signals74
Avg Return-1.58%
Long Lower Shadow
Score1.35/10
Win Rate45.65%
Hist. Signals46
Avg Return-2.39%
Score1.35/10
Win Rate45.65%
Hist. Signals46
Avg Return-2.39%
RSI Overbought
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return5.31%
Score6.83/10
Win Rate60.00%
Hist. Signals10
Avg Return5.31%
Technical Analysis of ATYR?
- ATYR presents a Netural setup with a Technical Score of 3.33/10. Key technical indicators highlight an RSI of 59.41 and a MACD of 0.04, with the trend anchored by the 50-Day SMA at 0.76. Traders should monitor key support at 0.78 and resistance at 0.87.
